DPP-4 inhibitors: A potential promising therapeutic target in prevention of atherosclerosis

被引：8
作者：
Yang, Chao-Jun
Fan, Zhi-Xing
Yang, Jun
Yang, Jian
机构：
[1] China Three Gorges Univ, Dept Cardiol, Coll Clin Med Sci 1, Yichang 443000, Hubei Province, Peoples R China
[2] China Three Gorges Univ, Inst Cardiovasc Dis, Yichang 443000, Hubei Province, Peoples R China
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2016年 / 202卷
基金：
中国国家自然科学基金;
关键词：
RECRUITMENT;
D O I：
10.1016/j.ijcard.2015.08.056
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：797 / 798
页数：2
相关论文
共 12 条
[1]   DPP-4 inhibition ameliorates atherosclerosis by priming monocytes into M2 macrophages [J].
Brenner, C. ;
Franz, W. M. ;
Kuehlenthal, S. ;
Kuschnerus, K. ;
Remma, F. ;
Gross, L. ;
Theiss, H. D. ;
Landmesser, U. ;
Kraenkel, N. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 199 :163-169
[2]   Short-term inhibition of DPP-4 enhances endothelial regeneration after acute arterial injury via enhanced recruitment of circulating progenitor cells [J].
Brenner, Christoph ;
Kraenkel, Nicolle ;
Kuehlenthal, Sarah ;
Israel, Lars ;
Remm, Friederike ;
Fischer, Cornelia ;
Herbach, Nadja ;
Speer, Timo ;
Grabmaier, Ulrich ;
Laskowski, Alexandra ;
Gross, Lisa ;
Theiss, Hans ;
Wanke, Ruediger ;
Landmesser, Ulf ;
Franz, Wolfgang-Michael .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 177 (01) :266-275
[3]   Dipeptidyl peptidase-4 inhibition by gemigliptin prevents abnormal vascular remodeling via NF-E2-related factor 2 activation [J].
Choi, Seung Hee ;
Park, Sungmi ;
Oh, Chang Joo ;
Leem, Jaechan ;
Park, Keun-Gyu ;
Lee, In-Kyu .
VASCULAR PHARMACOLOGY, 2015, 73 :11-19
[4]   Dipeptidyl Peptidase 4: A New Link between Diabetes Mellitus and Atherosclerosis? [J].
da Silva Junior, Wellington Santana ;
de Godoy-Matos, Amelio Fernando ;
Kraemer-Aguiar, Luiz Guilherme .
BIOMED RESEARCH INTERNATIONAL, 2015, 2015
[5]   DPP-4 Inhibitors Repress NLRP3 Inflammasome and Interleukin-1beta via GLP-1 Receptor in Macrophages Through Protein Kinase C Pathway [J].
Dai, Yao ;
Dai, Dongsheng ;
Wang, Xianwei ;
Ding, Zufeng ;
Mehta, Jawahar L. .
CARDIOVASCULAR DRUGS AND THERAPY, 2014, 28 (05) :425-432
[6]   DPP-4 inhibitors repress foam cell formation by inhibiting scavenger receptors through protein kinase C pathway [J].
Dai, Yao ;
Wang, Xianwei ;
Ding, Zufeng ;
Dai, Dongsheng ;
Mehta, Jawahar L. .
ACTA DIABETOLOGICA, 2014, 51 (03) :471-478
[7]   Anagliptin, a DPP-4 Inhibitor, Suppresses Proliferation of Vascular Smooth Muscles and Monocyte Inflammatory Reaction and Attenuates Atherosclerosis in Male apo E-Deficient Mice [J].
Ervinna, Nasib ;
Mita, Tomoya ;
Yasunari, Eisuke ;
Azuma, Kosuke ;
Tanaka, Rica ;
Fujimura, Satoshi ;
Sukmawati, Dewi ;
Nomiyama, Takashi ;
Kanazawa, Akio ;
Kawamori, Ryuzo ;
Fujitani, Yoshio ;
Watada, Hirotaka .
ENDOCRINOLOGY, 2013, 154 (03) :1260-1270
[8]   Dpp4 inhibition as a therapeutic strategy in cardiometabolic disease: Incretin-dependent and -independent function [J].
Gong, Quan ;
Rajagopalan, Sanjay ;
Zhong, Jixin .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 197 :170-179
[9]   Efficacy and safety of teneligliptin, a dipeptidyl peptidase-4 inhibitor, combined with metformin in Korean patients with type 2 diabetes mellitus: a 16-week, randomized, double-blind, placebo-controlled phase III trial [J].
Kim, M. K. ;
Rhee, E. -J. ;
Han, K. A. ;
Woo, A. C. ;
Lee, M. -K. ;
Ku, B. J. ;
Chung, C. H. ;
Kim, K. -A. ;
Lee, H. W. ;
Park, I. B. ;
Park, J. Y. ;
Jang, H. C. Chul ;
Park, K. S. ;
Jang, W. I. ;
Cha, B. Y. .
DIABETES OBESITY & METABOLISM, 2015, 17 (03) :309-312
[10]   Long-Term Dipeptidyl-Peptidase 4 Inhibition Reduces Atherosclerosis and Inflammation via Effects on Monocyte Recruitment and Chemotaxis [J].
Shah, Zubair ;
Kampfrath, Thomas ;
Deiuliis, Jeffrey A. ;
Zhong, Jixin ;
Pineda, Colleen ;
Ying, Zhekang ;
Xu, Xiaohua ;
Lu, Bo ;
Moffatt-Bruce, Susan ;
Durairaj, Rekha ;
Sun, Qinghua ;
Mihai, Georgeta ;
Maiseyeu, Andrei ;
Rajagopalan, Sanjay .
CIRCULATION, 2011, 124 (21) :2339-U135
12